Diagnamed Holdings Corp., a digital health artificial intelligence company, engages in the development and commercialization of digital therapeutics for people suffering from mental health and neurological disorders. It focuses on CERVAI, a brain health AI platform; and Health GenAI, a suite of generative AI solutions for the healthcare market that includes OpenAI's ChatGPT. The company also develops Dr. GENAI, a personal AI medical chatbot designed to give people to obtain fast and personalized medical information based on a person's unique medical condition. In addition, it is developing Brain Age, an electroencephalogram-based (EEG) machine-learning solution to detect an individual's brain age for use in clinic and at-home. The company is headquartered in Toronto, Canada.